Effect of an antagonistic analog of LH-RH on haloperidol-induced hyperprolactinemia in female rats

L. Debeljuk, I. Torres-Aleman, Andrew V Schally

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The effects of prolonged treatment with the antagonistic analog of LH-RH (N-Ac-D-p-Cl-Phe1,2, D-Trp3,D-Arg6,D-Ala10) LH-RH (ORG 30276) on the hyperprolactinemia induced by haloperidol were investigated in intact or ovariectomized female rats. Treatment with ORG 30276 for 20 days significantly reduced prolactin levels elevated by daily injections of haloperidol in intact as well as in ovariectomized rats. Administration of ORG 30276 also significantly decreased serum LH levels in both types of rats. It is concluded that the LH-RH antagonist ORG 30276 is able to counteract the hyperprolactinemic effect of haloperidol. This effect might be due to a blockade of the action of endogenous LH-RH on the gonadotrophs, which results in a suppressing of the paracrine action of these cells on the lactotroph.

Original languageEnglish
Pages (from-to)463-465
Number of pages3
JournalPeptides
Volume6
Issue number3
DOIs
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

Hyperprolactinemia
Haloperidol
Gonadotropin-Releasing Hormone
Rats
Lactotrophs
Gonadotrophs
Prolactin
Injections
Therapeutics
Serum

Keywords

  • LH, Pituitary
  • LH, Prolactin

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Effect of an antagonistic analog of LH-RH on haloperidol-induced hyperprolactinemia in female rats. / Debeljuk, L.; Torres-Aleman, I.; Schally, Andrew V.

In: Peptides, Vol. 6, No. 3, 01.01.1985, p. 463-465.

Research output: Contribution to journalArticle

@article{384b46d5a0394277b26b02903e29450f,
title = "Effect of an antagonistic analog of LH-RH on haloperidol-induced hyperprolactinemia in female rats",
abstract = "The effects of prolonged treatment with the antagonistic analog of LH-RH (N-Ac-D-p-Cl-Phe1,2, D-Trp3,D-Arg6,D-Ala10) LH-RH (ORG 30276) on the hyperprolactinemia induced by haloperidol were investigated in intact or ovariectomized female rats. Treatment with ORG 30276 for 20 days significantly reduced prolactin levels elevated by daily injections of haloperidol in intact as well as in ovariectomized rats. Administration of ORG 30276 also significantly decreased serum LH levels in both types of rats. It is concluded that the LH-RH antagonist ORG 30276 is able to counteract the hyperprolactinemic effect of haloperidol. This effect might be due to a blockade of the action of endogenous LH-RH on the gonadotrophs, which results in a suppressing of the paracrine action of these cells on the lactotroph.",
keywords = "LH, Pituitary, LH, Prolactin",
author = "L. Debeljuk and I. Torres-Aleman and Schally, {Andrew V}",
year = "1985",
month = "1",
day = "1",
doi = "10.1016/0196-9781(85)90111-1",
language = "English",
volume = "6",
pages = "463--465",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of an antagonistic analog of LH-RH on haloperidol-induced hyperprolactinemia in female rats

AU - Debeljuk, L.

AU - Torres-Aleman, I.

AU - Schally, Andrew V

PY - 1985/1/1

Y1 - 1985/1/1

N2 - The effects of prolonged treatment with the antagonistic analog of LH-RH (N-Ac-D-p-Cl-Phe1,2, D-Trp3,D-Arg6,D-Ala10) LH-RH (ORG 30276) on the hyperprolactinemia induced by haloperidol were investigated in intact or ovariectomized female rats. Treatment with ORG 30276 for 20 days significantly reduced prolactin levels elevated by daily injections of haloperidol in intact as well as in ovariectomized rats. Administration of ORG 30276 also significantly decreased serum LH levels in both types of rats. It is concluded that the LH-RH antagonist ORG 30276 is able to counteract the hyperprolactinemic effect of haloperidol. This effect might be due to a blockade of the action of endogenous LH-RH on the gonadotrophs, which results in a suppressing of the paracrine action of these cells on the lactotroph.

AB - The effects of prolonged treatment with the antagonistic analog of LH-RH (N-Ac-D-p-Cl-Phe1,2, D-Trp3,D-Arg6,D-Ala10) LH-RH (ORG 30276) on the hyperprolactinemia induced by haloperidol were investigated in intact or ovariectomized female rats. Treatment with ORG 30276 for 20 days significantly reduced prolactin levels elevated by daily injections of haloperidol in intact as well as in ovariectomized rats. Administration of ORG 30276 also significantly decreased serum LH levels in both types of rats. It is concluded that the LH-RH antagonist ORG 30276 is able to counteract the hyperprolactinemic effect of haloperidol. This effect might be due to a blockade of the action of endogenous LH-RH on the gonadotrophs, which results in a suppressing of the paracrine action of these cells on the lactotroph.

KW - LH, Pituitary

KW - LH, Prolactin

UR - http://www.scopus.com/inward/record.url?scp=0022203389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022203389&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(85)90111-1

DO - 10.1016/0196-9781(85)90111-1

M3 - Article

C2 - 3906589

AN - SCOPUS:0022203389

VL - 6

SP - 463

EP - 465

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 3

ER -